The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials

CONCLUSIONS: There is a lack of RTQA utilization and transparency in RT clinical trials. It is imperative for RT trials to include increased QA for safe, consistent, and high-quality RT planning and delivery.PMID:34838891 | DOI:10.1016/j.radonc.2021.11.018

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - November 28, 2021 Category: Radiology Authors: Kelsey L Corrigan Stephen Kry Rebecca M Howell Ramez Kouzy Joseph Abi Jaoude Roshal R Patel Anuja Jhingran Cullen Taniguchi Albert C Koong Mary Fran McAleer Paige Nitsch Claus R ödel Emmanouil Fokas Bruce D Minsky Prajnan Das C David Fuller Ethan B Ludmi Source Type: research